Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 1
1991 1
1997 1
1998 3
1999 2
2004 2
2006 3
2012 3
2014 1
2017 4
2018 5
2019 1
2020 2
2021 6
2022 9
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines.
Valdes-Balbin Y, Santana-Mederos D, Paquet F, Fernandez S, Climent Y, Chiodo F, Rodríguez L, Sanchez Ramirez B, Leon K, Hernandez T, Castellanos-Serra L, Garrido R, Chen GW, Garcia-Rivera D, Rivera DG, Verez-Bencomo V. Valdes-Balbin Y, et al. Among authors: verez bencomo v. ACS Cent Sci. 2021 May 26;7(5):757-767. doi: 10.1021/acscentsci.1c00216. Epub 2021 Apr 19. ACS Cent Sci. 2021. PMID: 34075345 Free PMC article. Review.
Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats.
Oliva-Hernández R, Fariñas-Medina M, Hernández-Salazar T, Oyarzabal-Vera A, Infante-Bourzac JF, Rodríguez-Salgueiro S, Rodríguez-Noda LM, Arranguren-Masorra Y, Climent-Ruíz Y, Fernández-Castillo S, G-Rivera D, Santana-Mederos D, Sánchez-Ramírez B, García-Rivera D, Valdés-Barbín Y, Vérez-Bencomo V. Oliva-Hernández R, et al. Among authors: verez bencomo v. Toxicology. 2022 Mar 29;471:153161. doi: 10.1016/j.tox.2022.153161. Online ahead of print. Toxicology. 2022. PMID: 35364223 Free PMC article.
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles.
Santana-Mederos D, Perez-Nicado R, Climent Y, Rodriguez L, Ramirez BS, Perez-Rodriguez S, Rodriguez M, Labrada C, Hernandez T, Diaz M, Orosa I, Ramirez U, Oliva R, Garrido R, Cardoso F, Landys M, Martinez R, Gonzalez H, Hernandez T, Ochoa-Azze R, Perez JL, Enriquez J, Gonzalez N, Infante Y, Espinosa LA, Ramos Y, González LJ, Valenzuela C, Casadesus AV, Fernandez B, Rojas G, Pérez-Massón B, Tundidor Y, Bermudez E, Plasencia CA, Boggiano T, Ojito E, Chiodo F, Fernandez S, Paquet F, Fang C, Chen GW, Rivera DG, Valdes-Balbin Y, Garcia-Rivera D, Verez Bencomo V. Santana-Mederos D, et al. Among authors: verez bencomo v. RSC Chem Biol. 2021 Dec 8;3(2):242-249. doi: 10.1039/d1cb00200g. eCollection 2022 Feb 9. RSC Chem Biol. 2021. PMID: 35360883 Free PMC article.
SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies.
Valdes-Balbin Y, Santana-Mederos D, Quintero L, Fernández S, Rodriguez L, Sanchez Ramirez B, Perez-Nicado R, Acosta C, Méndez Y, Ricardo MG, Hernandez T, Bergado G, Pi F, Valdes A, Carmenate T, Ramirez U, Oliva R, Soubal JP, Garrido R, Cardoso F, Landys M, Gonzalez H, Farinas M, Enriquez J, Noa E, Suarez A, Fang C, Espinosa LA, Ramos Y, González LJ, Climent Y, Rojas G, Relova-Hernández E, Cabrera Infante Y, Losada SL, Boggiano T, Ojito E, León K, Chiodo F, Paquet F, Chen GW, Rivera DG, Garcia-Rivera D, Verez Bencomo V. Valdes-Balbin Y, et al. Among authors: verez bencomo v. ACS Chem Biol. 2021 Jul 16;16(7):1223-1233. doi: 10.1021/acschembio.1c00272. Epub 2021 Jul 4. ACS Chem Biol. 2021. PMID: 34219448 Free article.
Corrigendum to "Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein" [Vaccine 40(20) (2022) 2856-2868].
Pouriayevali MH, Teimoori A, Esmaeili S, Abdoli A, Doroud D, Salehi-Vaziri M, Shahali M, Kadkhodazadeh M, Sabouni T, Ali Khosravi M, Panahi M, Khoshroo F, Bahmanjeh A, Valdes-Balbin Y, Garcia-Rivera D, Verez-Bencomo V, Biglari A, Baesi K. Pouriayevali MH, et al. Among authors: verez bencomo v. Vaccine. 2022 Nov 15;40(48):7009. doi: 10.1016/j.vaccine.2022.10.019. Epub 2022 Oct 28. Vaccine. 2022. PMID: 36374711 Free PMC article. No abstract available.
Multicomponent polysaccharide-protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates.
Méndez Y, Chang J, Humpierre AR, Zanuy A, Garrido R, Vasco AV, Pedroso J, Santana D, Rodríguez LM, García-Rivera D, Valdés Y, Vérez-Bencomo V, Rivera DG. Méndez Y, et al. Among authors: verez bencomo v. Chem Sci. 2018 Jan 19;9(9):2581-2588. doi: 10.1039/c7sc05467j. eCollection 2018 Mar 7. Chem Sci. 2018. PMID: 29719713 Free PMC article.
Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction.
Zhang Q, Gimeno A, Santana D, Wang Z, Valdés-Balbin Y, Rodríguez-Noda LM, Hansen T, Kong L, Shen M, Overkleeft HS, Vérez-Bencomo V, van der Marel GA, Jiménez-Barbero J, Chiodo F, Codée JDC. Zhang Q, et al. Among authors: verez bencomo v. ACS Cent Sci. 2019 Aug 28;5(8):1407-1416. doi: 10.1021/acscentsci.9b00454. Epub 2019 Jul 24. ACS Cent Sci. 2019. PMID: 31482123 Free PMC article.
Expanding the Scope of Ugi Multicomponent Bioconjugation to Produce Pneumococcal Multivalent Glycoconjugates as Vaccine Candidates.
Humpierre AR, Zanuy A, Saenz M, Garrido R, Vasco AV, Pérez-Nicado R, Soroa-Milán Y, Santana-Mederos D, Westermann B, Vérez-Bencomo V, Méndez Y, García-Rivera D, Rivera DG. Humpierre AR, et al. Among authors: verez bencomo v. Bioconjug Chem. 2020 Sep 16;31(9):2231-2240. doi: 10.1021/acs.bioconjchem.0c00423. Epub 2020 Sep 2. Bioconjug Chem. 2020. PMID: 32809806
46 results